Glutaryl cephalosporin amidase from pseudomonas diminuta BS-203

Details for Australian Patent Application No. 2001296886 (hide)

Owner Bristol-Myers Squibb Company

Inventors Burnett Jr., William V.; Binder, Ross; Franceschini, Thomas J.; Liu, Suo Win; Politino, Michael; Brown, Joanne L.; Tonzi, Sean M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001296886

PCT Pub. Number WO02/24879

Priority 60/234,532 22.09.00 US

Filing date 19 September 2001

Wipo publication date 2 April 2002

Acceptance publication date 14 September 2006

International Classifications

C12N 9/80 (2006.01) Enzymes, e.g. ligases (6.)

C07K 14/21 (2006.01) Peptides having more than 20 amino acids

C12P 35/02 (2006.01) Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin

Event Publications

14 September 2006 Application Accepted

  Published as AU-B-2001296886

1 February 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001296887

2001296885